Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: ProKidney Corp., 3 years.
ProKidney Corp.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
ProKidney Corp. May 28, 202699.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 20, 2026 | ProKidney Corp. | Open-market sale | −222,948 | $1.42 | $316,586 |
| Aug 20, 2026 | ProKidney Corp. | Open-market sale | −27,052 | $1.42 | $38,414 |
| Aug 19, 2026 | ProKidney Corp. | Open-market sale | −222,949 | $1.44 | $321,047 |
| Aug 19, 2026 | ProKidney Corp. | Open-market sale | −27,051 | $1.44 | $38,953 |
| Aug 18, 2026 | ProKidney Corp. | Open-market sale | −229,338 | $1.37 | $314,193 |
| Aug 18, 2026 | ProKidney Corp. | Open-market sale | −27,826 | $1.37 | $38,122 |
| Aug 4, 2026 | ProKidney Corp. | Derivative conversion | +81,929 | — | — |
| Aug 4, 2026 | ProKidney Corp. | Derivative conversion | +675,235 | — | — |
| Nov 13, 2025 | ProKidney Corp. | Open-market sale | −447,803 | $2.37 | $1,061,293 |
| Nov 13, 2025 | ProKidney Corp. | Open-market sale | −54,333 | $2.37 | $128,769 |
| Nov 12, 2025 | ProKidney Corp. | Open-market sale | −227,431 | $2.72 | $618,612 |
| Nov 12, 2025 | ProKidney Corp. | Open-market sale | −27,595 | $2.72 | $75,058 |
| Feb 4, 2025 | ProKidney Corp. | Derivative conversion | +81,928 | — | — |
| Feb 4, 2025 | ProKidney Corp. | Derivative conversion | +675,234 | — | — |
Questions about Brian Jg Pereira
What boards is Brian Jg Pereira on?
Brian Jg Pereira sits on the board of ProKidney Corp.
How long has Brian Jg Pereira served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.